Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma
- Shlomit Yust-Katz
- , Diane Liu
- , Ying Yuan
- , Vivien Liu
- , Sanghee Kang
- , Morris Groves
- , Vinay Puduvalli
- , Victor Levin
- , Charles Conrad
- , Howard Colman
- , Sigmonid Hsu
- , W. K.Alfred Yung
- , Mark R. Gilbert*
*Corresponding author for this work
- University of Texas Health Science Center at Houston
- Austin Brain Tumor Center
- Redwood City Hospital
- University of Utah
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations